Autologous Stem-Cell Transplantation for Poor-Risk and Relapsed Intermediate- and High-Grade Non-Hodgkin's Lymphoma

This publication has 21 references indexed in Scilit:

• Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.
  Journal of Clinical Oncology, 1998
• VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
  Journal of Clinical Oncology, 1998
• Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.
  Journal of Clinical Oncology, 1997
• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1995
• BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.
  Journal of Clinical Oncology, 1995
• High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.
  Journal of Clinical Oncology, 1994
• Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?
  Blood, 1994
• High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.
  Journal of Clinical Oncology, 1993
• High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1987
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958